{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:31:20Z","timestamp":1761661880029},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,9,27]],"date-time":"2002-09-27T00:00:00Z","timestamp":1033084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Microbiology and Immunology"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p>In this study, we evaluated the current effectiveness of 11 \u03b2\u2010lactam antibiotics for treatment of orofacial odontogenic infections by determining the antimicrobial susceptibility of the major pathogens. The antimicrobial susceptibilities of viridans streptococci (<jats:italic>n<\/jats:italic>\u2003=\u200347), <jats:italic>Peptostreptococcus<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2003=\u200367), <jats:italic>Porphyromonas<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2003=\u200318), <jats:italic>Fusobacterium<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2003=\u200357), black\u2010pigmented <jats:italic>Prevotella<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2003=\u200359) and non\u2010pigmented <jats:italic>Prevotella<\/jats:italic> (<jats:italic>n<\/jats:italic>\u2003=\u200347) isolated from pus specimens of 93 orofacial odontogenic infections to penicillin G, cefmetazole, flomoxef, cefoperazone, cefoperazone\/sulbactam, ceftazidime, cefpirome, cefepime, cefoselis, imipenem and faropenem were determined using the agar dilution method. Penicillin G, most cephalosporins, imipenem and faropenem worked well against viridans streptococci, <jats:italic>Peptostreptococcus<\/jats:italic>, <jats:italic>Porphyromonas<\/jats:italic> and <jats:italic>Fusobacterium<\/jats:italic>. Penicillin G and most cephalosporins, including fourth\u2010generation agents, were not effective against \u03b2\u2010lactamase\u2010positive <jats:italic>Prevotella<\/jats:italic>, though they were effective against \u03b2\u2010lactamase\u2010negative strains. Cefmetazole, cefoperazone\/sulbactam, imipenem and faropenem expressed powerful antimicrobial activity against \u03b2\u2010lactamase\u2010positive <jats:italic>Prevotella<\/jats:italic>. In conclusion, penicillins have the potential to be first\u2010line agents in the treatment of orofacial odontogenic infections. Most of the other \u03b2\u2010lactam antibiotics, including fourth\u2010generation cephalosporins, were not found to have greater effectiveness than penicillins. In contrast, cefmetazole, cefoperazone\/sulbactam, imipenem and faropenem were found to have greater effectiveness than penicillins.<\/jats:p>","DOI":"10.1034\/j.1399-302x.2002.170504.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T15:52:21Z","timestamp":1047484341000},"page":"285-289","source":"Crossref","is-referenced-by-count":53,"title":["Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 \u2028\u03b2\u2010lactam antibiotics"],"prefix":"10.1111","volume":"17","author":[{"given":"T.","family":"Kuriyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,9,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/B978-0-12-256745-2.50043-X","volume-title":"Anaerobic infections in humans.","author":"Finegold SM","year":"1989"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(90)90109-6"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2000.109639"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302x.2001.160102.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","unstructured":"KuriyamaT KarasawaT NakagawaK YamamotoE NakamuraS.Bacteriology and antimicrobial susceptibility of gram\u2010positive cocci isolated from pus specimens of orofacial odontogenic infections.Oral Microbiol Immunol2002:17:132\u2013135.","DOI":"10.1046\/j.0902-0055.2001.00098.x"},{"key":"e_1_2_6_7_2","first-page":"219","volume-title":"Oral and maxillofacial surgery.","author":"Laskin DM","year":"1985"},{"key":"e_1_2_6_8_2","first-page":"1073","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Mandell GL","year":"1996"},{"key":"e_1_2_6_9_2","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria. 4th edition. Approved standard. NCCLS document M11\u2010A4.","author":"National Committee for Clinical Laboratory Standards.","year":"1997"},{"key":"e_1_2_6_10_2","volume-title":"Methods for antimicrobial susceptibility tests for bacteria that grow aerobically. 4th edition. Approved standard. NCCLS document M7\u2010A4.","author":"National Committee for Clinical Laboratory Standards.","year":"1998"},{"key":"e_1_2_6_11_2","first-page":"392","volume-title":"Contemporary Oral and Maxillofacial Surgery.","author":"Peterson LJ","year":"1998"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964256"},{"key":"e_1_2_6_13_2","first-page":"508","article-title":"Antimicrobial treatment options in the management of odontogenic infections","volume":"64","author":"Sandor GK","year":"1998","journal-title":"J Can Dent Assoc"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2599"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.Supplement_3.S417"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.6.1219"}],"container-title":["Oral Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-302X.2002.170504.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-302X.2002.170504.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-302X.2002.170504.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T12:52:50Z","timestamp":1697547170000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-302X.2002.170504.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,27]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1034\/j.1399-302X.2002.170504.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-302x.2002.170504.x","archive":["Portico"],"relation":{},"ISSN":["0902-0055","1399-302X"],"issn-type":[{"value":"0902-0055","type":"print"},{"value":"1399-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,27]]}}}